PROTIA Showcases Advanced Veterinary Diagnostic Technologies at WVC 2025

PROTIA, a global leader in in-vitro diagnostic medical devices, will participate in the Western Veterinary Conference (WVC) from March 2 to 5, presenting groundbreaking diagnostic technologies for veterinary professionals. The company will showcase specialized diagnostic kits designed to rapidly identify allergens and assess immune health in companion and large animals.

The company's product lineup includes the 'ANITIA Canine/Feline IgE' diagnostic kit, which enables veterinarians to quickly identify and address pet allergies. The 'ANITIA Equine IgE' kit allows for comprehensive allergy testing in horses, utilizing a Parallel Line Array system to diagnose 120 potential allergens through equine serum.

Another significant offering is the 'AniCheck Bovine/Equine IgG' technology, which measures immunoglobulin G concentration in colostrum within 10 minutes. This innovation helps select high-quality colostrum for newborn calves and foals, potentially increasing survival rates and reducing disease incidence.

With over 20,000 expected visitors and more than 600 participating companies, the WVC represents a critical platform for PROTIA to introduce its innovative diagnostic technologies to the global veterinary market. The conference provides an opportunity for international collaboration and knowledge sharing among veterinary professionals.

By presenting these advanced diagnostic solutions, PROTIA aims to enhance animal healthcare through rapid, accurate diagnostic technologies that can improve treatment strategies and preventive care for both companion and large animals.